UNAIDS estimated that there were some ******* people worldwide that died from acquired immune deficiency syndrome (AIDS) in 2024. This statistic depicts the total number of annual AIDS-related deaths worldwide from 2000 to 2024. HIV/AIDS burden A majority of countries with the highest burden due to HIV and AIDS are in Africa- in 2024, the highest number of AIDS-related deaths occurred in South Africa and Mozambique and the highest prevalence of HIV was found in Eswatini. Although access to life-saving antiretroviral therapy treatment (ART) has increased globally over recent years, many individuals living with HIV still lack access to ART. Barriers and interventions In part due to the development of ART, the number of people living with HIV worldwide is continuing to increase, reaching almost ** million in 2024. Important public health measures to combat the burden of the disease include a combination of biomedical and behavioral interventions such as pre- and post-exposure prophylaxis, and context-specific structural interventions to reduce barriers to supplies and education. One prominent barrier faced by those living with HIV is stigma, which can often cause disadvantages in many areas of life, including employment, use of health services, and social support.

HIV/AIDS deaths in the U.S. have dropped significantly in recent years. In 1995, the death rate from HIV per 100,000 people was ****. That number has since decreased to *** per 100,000 as of 2023. The reduction in the HIV death rate in the U.S. can be attributed to an increase in access to HIV medications. HIV/AIDS in the U.S. Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body can no longer fight off infections. Among all U.S. states, Georgia, followed by Florida and Louisiana, had the highest rates of new HIV diagnoses in 2022. HIV/AIDS treatments in the U.S. HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the National Institutes of Health (NIH) and the Ryan White Program. The top HIV drug worldwide, based on revenue generated in 2023 was Biktarvy. Around the world, access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.

AIDS estimated deaths (UNAIDS estimates) in Liberia was reported at 920 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Liberia - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

This scatter chart displays incidence of HIV (per 1,000 uninfected population) against death rate (per 1,000 people) in Georgia. The data is about countries per year.

Prevalence of HIV, total (% of population ages 15-49) in North America was reported at 0.4 % in 2019, according to the World Bank collection of development indicators, compiled from officially recognized sources. North America - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

This dataset is about countries per year in Burkina Faso. It has 64 rows. It features 4 columns: country, incidence of HIV, and death rate.

AIDS estimated deaths (UNAIDS estimates) in Namibia was reported at 3100 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Namibia - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The average for 2022 based on 135 countries was 1.66 percent. The highest value was in Swaziland: 25.9 percent and the lowest value was in Afghanistan: 0.1 percent. The indicator is available from 1990 to 2022. Below is a chart for all countries where data are available.

AIDS estimated deaths (UNAIDS estimates) in Haiti was reported at 1600 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Haiti - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The USA: Prevalence of HIV, percent of the population ages 15-49: The latest value from 2021 is 0.4 percent, unchanged from 0.4 percent in 2020. In comparison, the world average is 1.63 percent, based on data from 143 countries. Historically, the average for the USA from 2010 to 2021 is 0.4 percent. The minimum value, 0.4 percent, was reached in 2010 while the maximum of 0.4 percent was recorded in 2010.

Prevalence of HIV, total (% of population ages 15-49) in Brazil was reported at 0.6 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Brazil - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

In 2000, there were around 511 deaths due to human immunodeficiency virus (HIV) in Canada. By 2023, that figure had decreased to around 126 deaths. This statistic displays the number of deaths due to human immunodeficiency virus in Canada for HIV from 2000 to 2023.

India: Prevalence of HIV, percent of the population ages 15-49: The latest value from 2022 is 0.2 percent, unchanged from 0.2 percent in 2021. In comparison, the world average is 1.66 percent, based on data from 135 countries. Historically, the average for India from 1990 to 2022 is 0.35 percent. The minimum value, 0.1 percent, was reached in 1990 while the maximum of 0.6 percent was recorded in 1998.

This scatter chart displays death rate (per 1,000 people) against incidence of HIV (per 1,000 uninfected population) in Central America. The data is about countries per year.

Prevalence of HIV, total (% of population ages 15-49) in France was reported at 0.3 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. France - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

In 2024, the estimated number of deaths from acquired immunodeficiency syndrome (AIDS) in South Africa reached ******. This was slightly higher compared to the previous year, when the AIDS related deaths in the country amounted to ******. From 2006 onwards (except in 2016), the number of AIDS-related deaths dropped annually.

In 2022, the number of deaths from AIDS in Spain amounted to *** cases, down from *** deaths reported a year prior. This figure showed a significant decline since 2006, when deaths related to AIDS totaled ***** cases in the European country. As of 2021, nearly ***** new cases of HIV were diagnosed in Spain.

The graph illustrates the prevalence of HIV among adults in different world regions in 2000 and 2024. For 2024, UNAIDS estimated that *** percent of the adult population aged between 15 and 49 years in Latin America was living with HIV.

Niger: Prevalence of HIV, percent of the population ages 15-49: The latest value from 2022 is 0.2 percent, unchanged from 0.2 percent in 2021. In comparison, the world average is 1.66 percent, based on data from 135 countries. Historically, the average for Niger from 1990 to 2022 is 0.47 percent. The minimum value, 0.2 percent, was reached in 2016 while the maximum of 0.8 percent was recorded in 1997.